FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Benjamin Bonavida

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Living Beings

Mouse

Procedures

Flow Cytometry

Co-author Network

Publications

TOP 3
Valentina Rapozzi; Benjamin Bonavida; Emilia Della Pietra; Marina Zacchigna; Sonia Zorzet; Luigi E Xodo
Nitric oxide-mediated activity in anti-cancer photodynamic therapy.
Sara Huerta-Yepez; Mario I Vega; Guillermina Baay-Guzman; Stavroula Baritaki; Angeles Hernandez-Cueto; Marco Antonio Hernandez-Luna; Benjamin Bonavida
Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
Eric Sanchez; Regina A Swift; Robert A Vescio; Cathy S Wang; Gabriel N Waterman; Ori Yellin; Cameryn P Ahles; Ralph V Boccia; Benjamin Bonavida; Haiming Chen; John Crowley; Marissa P Dreyer; Dylan T Kirk; Alex Kitto; Jennifer Li; Mingjie Li; Erik Madden; Cydney M Nichols; Austin Robinson; James R Berenson
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Benjamin Bonavida (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Valentina Rapozzi; Benjamin Bonavida; Emilia Della Pietra; Marina Zacchigna; Sonia Zorzet; Luigi E Xodo
Nitric oxide-mediated activity in anti-cancer photodynamic therapy.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2013;30():26-35.
2013: Sara Huerta-Yepez; Mario I Vega; Guillermina Baay-Guzman; Stavroula Baritaki; Angeles Hernandez-Cueto; Marco Antonio Hernandez-Luna; Benjamin Bonavida
Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2013;29():17-24.
2012: Eric Sanchez; Regina A Swift; Robert A Vescio; Cathy S Wang; Gabriel N Waterman; Ori Yellin; Cameryn P Ahles; Ralph V Boccia; Benjamin Bonavida; Haiming Chen; John Crowley; Marissa P Dreyer; Dylan T Kirk; Alex Kitto; Jennifer Li; Mingjie Li; Erik Madden; Cydney M Nichols; Austin Robinson; James R Berenson
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival.
British journal of haematology 2012;158(6):727-38.
2012: Hong Liu; Manuel Penichet; Samantha Tamashiro; Youhua Yu; Stavroula Baritaki; James Berenson; Haiming Chen; Benjamin Bonavida
TRAF6 activation in multiple myeloma: a potential therapeutic target.
Clinical lymphoma, myeloma & leukemia 2012;12(3):155-63.
2012: Yoichi Mizutani; Yoji Katsuoka; Benjamin Bonavida
Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer.
International journal of oncology 2012;40(4):1246-50.
2012: Melisa A Martinez-Paniagua; Gabriel G Vega; Mario I Vega; Stavroula Baritaki; Kandasamy Hariharan; Sara Huerta-Yepez; Benjamin Bonavida
Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.
Molecular cancer therapeutics 2012;11(3):572-81.
2012: Guillermina J Baay-Guzman; Ilona G Bebenek; Benjamin Bonavida; Eduardo A Garcia-Zepeda; Oliver Hankinson; Rogelio Hernandez-Pando; Eric Kleerup; Marc Riedl; Donald P Tashkin; Mario I Vega; Michelle Zeidler; Gabriela Antonio-Andres; Sara Huerta-Yepez
HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation.
Respiratory research 2012;13():60.
2011: José A Rodríguez; Sokuntheavy So; David Avila; Benjamin Bonavida; David Casero; Andrew C Charles; Tracy R Daniels; Gustavo Helguera; Richard Leuchter; Héctor E López-Valdés; R0SENDO LURIA-PEREZ; Otoniel Martínez-Maza; Elizabeth Ortiz-Sánchez; Shabnum Patel; Matteo Pellegrini; Manuel L Penichet
Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.
Leukemia & lymphoma 2011;52(11):2169-78.
2011: Melisa A Martínez-Paniagua; Vianney F Ortiz-Navarrete; Stavroula Baritaki; Benjamin Bonavida; Cesar González-Bonilla; Sara Huerta-Yepez; Mario I Vega
Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis.
Cell cycle (Georgetown, Tex.) 2011;10(16):2792-805.
2011: Tracy R Daniels; Gustavo Helguera; R0SENDO LURIA-PEREZ; Otoniel Martínez-Maza; Elizabeth Ortiz-Sánchez; Benjamin Bonavida; Ruben A. Quintero; Manuel L Penichet
An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2011;34(6):500-8.
2011: Stavroula Baritaki; Loredana Militello; Graziella Malaponte; Demetrios A Spandidos; Margarita Salcedo; Benjamin Bonavida
The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
International journal of oncology 2011;38(6):1683-94.
2011: Eric Sanchez; Jing Shen; Jeffrey Steinberg; Mingjie Li; Cathy Wang; Benjamin Bonavida; Haiming Chen; Zhi-Wei Li; James R Berenson
The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo.
Leukemia research 2011;35(3):373-9.
2011: Ali R Jazirehi; Stavroula Baritaki; Richard C Koya; Benjamin Bonavida; James S Economou
Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.
Cancer research 2011;71(4):1406-17.
2011: Benjamin Bonavida; H Chen; Sara Huerta-Yepez; H Liu; Stavroula Baritaki; Mario I Vega; James R Berenson
Overexpression of Yin Yang 1 in the pathogenesis of human hematopoietic malignancies.
Critical reviews in oncogenesis 2011;16(3-4):261-7.
2011: Benjamin Bonavida; Stavroula Baritaki
The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
Critical reviews in oncogenesis 2011;16(3-4):211-26.
2011: Benjamin Bonavida
Preface: special issue on yin yang 1 and oncogenesis.
Critical reviews in oncogenesis 2011;16(3-4):141-2.
2011: Sara Huerta-Yepez; Vei Mah; Erin L Maresh; Clara M Rivera-Pazos; Mario I Vega; Nam K Yoon; Benjamin Bonavida; Devasis Chatterjee; David Chia; Angeles Hernandez-Cueto; Steve Horvath; Lee Goodglick
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.
BMC cancer 2011;11():259.
2011: Ali R Jazirehi; Benjamin Bonavida
Development of rituximab-resistant B-NHL clones: an in vitro model for studying tumor resistance to monoclonal antibody-mediated immunotherapy.
Methods in molecular biology (Clifton, N.J.) 2011;731():407-19.
2011: Mario I Vega; Stavroula Baritaki; Sara Huerta-Yepez; Melisa A Martinez-Paniagua; Benjamin Bonavida
A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.
Leukemia & lymphoma 2011;52(1):108-21.
2011: Benjamin Bonavida; Stavroula Baritaki
Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2011;24(1):1-7.
2010: Stavroula Baritaki; Sara Huerta-Yepez; Anna Sahakyan; Iordanis Karagiannides; Kyriaki Bakirtzi; Ali R Jazirehi; Benjamin Bonavida
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP.
Cell cycle (Georgetown, Tex.) 2010;9(24):4931-40.
2010: Yoichi Mizutani; Yoji Katsuoka; Benjamin Bonavida
Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy.
International journal of oncology 2010;37(2):503-8.
2010: Haiming Chen; Cathy S Wang; Mingjie Li; Eric Sanchez; Jennifer Li; Ariana Berenson; Eric Wirtschafter; James Wang; Jing Shen; Zhiwei Li; Benjamin Bonavida; James R Berenson
A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
International journal of oncology 2010;37(1):71-9.
2010: Eriko Suzuki; Tracy R Daniels; Gustavo Helguera; Manuel L Penichet; Kazuo Umezawa; Benjamin Bonavida
Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis.
International journal of oncology 2010;36(5):1299-307.
2010: Eric Sanchez; Mingjie Li; Jeffrey A Steinberg; Cathy Wang; Jing Shen; Benjamin Bonavida; Zhi-Wei Li; Haiming Chen; James R Berenson
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan.
British journal of haematology 2010;148(4):569-81.
2010: Stavroula Baritaki; Benjamin Bonavida
Viral infection and cancer: the NF-kappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes.
Critical reviews in immunology 2010;30(1):31-46.
2009: Mario I Vega; Melisa Martínez-Paniagua; Sara Huerta-Yepez; Cesar González-Bonilla; Norio Uematsu; Benjamin Bonavida
Dysregulation of the cell survival/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization.
International journal of oncology 2009;35(6):1289-96.
2009: Mario I Vega; Sara Huerta-Yepez; Melisa Martinez-Paniagua; Bernardo Martinez-Miguel; Rogelio Hernandez-Pando; Cesar R González-Bonilla; Paul Chinn; Nabil Hanna; Kandasamy Hariharan; Ali R Jazirehi; Benjamin Bonavida
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(21):6582-94.
2009: Stavroula Baritaki; Kam Yeung; Michael Palladino; James Berenson; Benjamin Bonavida
Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.
Cancer research 2009;69(21):8376-85.
2009: Stavroula Baritaki; A Chapman; Kam Yeung; Demetrios A Spandidos; M Palladino; Benjamin Bonavida
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
Oncogene 2009;28(40):3573-85.
2009: Sebastian Sieber; Georg Gdynia; Wilfried Roth; Benjamin Bonavida; Thomas Efferth
Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate.
International journal of oncology 2009;35(1):149-58.
2009: Apostolos Zaravinos; Peggy Kanellou; Stavroula Baritaki; Benjamin Bonavida; Demetrios A Spandidos
BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma.
Cell cycle (Georgetown, Tex.) 2009;8(9):1402-8.
2009: Sergio Huerta; Guillermina Baay-Guzman; Cesar R Gonzalez-Bonilla; Edward H Livingston; Sara Huerta-Yepez; Benjamin Bonavida
In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate: Involvement of AIF.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2009;20(3):182-94.
2009: Haiming Chen; Richard A Campbell; Yunchao Chang; Mingjie Li; Cathy S Wang; Jennifer Li; Eric Sanchez; Michael Share; Jeffrey Steinberg; Ariana Berenson; Dror Shalitin; Zhaohui Zeng; Dorina Gui; Pablo Perez-Pinera; Ronald J Berenson; Jonathan Said; Benjamin Bonavida; Thomas F Deuel; James R Berenson
Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.
Blood 2009;113(9):1992-2002.
2009: Stavroula Baritaki; Anthoula M Chatzinikola; Antonios F Vakis; Nikolaos Soulitzis; Dimitris A Karabetsos; Ioannis Neonakis; Benjamin Bonavida; Demetrios A Spandidos
YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels.
Cancer investigation 2009;27(2):184-92.
2009: Sara Huerta-Yepez; Mario Vega; Saul E Escoto-Chavez; Benjamin Murdock; Toshiyuki Sakai; Stavroula Baritaki; Benjamin Bonavida
Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2009;20(1):39-52.
2009: Nam K Yoon; David B Seligson; David Chia; Yahya Elshimali; Giri Sulur; Ai Li; Steve Horvath; Erin Maresh; Vei Mah; Shikha Bose; Benjamin Bonavida; Lee Goodglick
Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.
Cancer biomarkers : section A of Disease markers 2009;5(4):215-24.
2009: Katherine Wu; Benjamin Bonavida
The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs.
Critical reviews in immunology 2009;29(3):241-54.
2009: Alina Katsman; Kazuo Umezawa; Benjamin Bonavida
Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ.
Current pharmaceutical design 2009;15(7):792-808.
2009: E Ortiz-Sánchez; Tracy R Daniels; Gustavo Helguera; Otoniel Martinez-Maza; Benjamin Bonavida; Manuel L Penichet
Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.
Leukemia 2009;23(1):59-70.
2008: Sergio Huerta; Sapna Chilka; Benjamin Bonavida
Nitric oxide donors: novel cancer therapeutics (review).
International journal of oncology 2008;33(5):909-27.
2008: Mario I Vega; Melissa Martinez-Paniagua; Ali R Jazirehi; Sara Huerta-Yepez; Kazuo Umezawa; Otoniel Martinez-Maza; Benjamin Bonavida
The NF-kappaB inhibitors (bortezomib and DHMEQ) sensitise rituximab-resistant AIDS-B-non-Hodgkin lymphoma to apoptosis by various chemotherapeutic drugs.
Leukemia & lymphoma 2008;49(10):1982-94.
2008: Benjamin Bonavida; Stavroula Baritaki; Sara Huerta-Yepez; Mario I Vega; Devasis Chatterjee; Kam Yeung
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2008;19(2):152-7.
2008: Zhi-Wei Li; Haiming Chen; Richard A Campbell; Benjamin Bonavida; James R Berenson
NF-kappaB in the pathogenesis and treatment of multiple myeloma.
Current opinion in hematology 2008;15(4):391-9.
2008: Stavroula Baritaki; Eriko Suzuki; Kazuo Umezawa; Demetrios A Spandidos; James Berenson; Tracy R Daniels; Manuel L Penichet; Ali R Jazirehi; Michael Palladino; Benjamin Bonavida
Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(9):6199-210.
2008: Ayhan Bilir; Mine Erguven; Gulperi Oktem; Aysegul Ozdemir; Atilla Uslu; Esin Aktas; Benjamin Bonavida
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
International journal of oncology 2008;32(4):829-39.
2007: David Seligson; Fumiya Hongo; Sara Huerta-Yepez; Yoichi Mizutani; Tsuneharu Miki; Hong Yu; Steve Horvath; David Chia; Lee Goodglick; Benjamin Bonavida
Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6056-63.
2007: Stavroula Baritaki; Alina Katsman; Devasis Chatterjee; Kam C Yeung; Demetrios A Spandidos; Benjamin Bonavida
Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(8):5441-53.
2007: Ji Yeun Lee; Sara Huerta-Yepez; Mario Vega; Stavroula Baritaki; Demetrios A Spandidos; Benjamin Bonavida
The NO TRAIL to YES TRAIL in cancer therapy (review).
International journal of oncology 2007;31(4):685-91.
2007: E Suzuki; K Umezawa; Benjamin Bonavida
Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.
Oncogene 2007;26(42):6184-93.
2007: Sergio Huerta; John H Heinzerling; Yu-Mei Anguiano-Hernandez; Sara Huerta-Yepez; Jeffrey Lin; David Chen; Benjamin Bonavida; Edward H Livingston
Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
The Journal of surgical research 2007;142(1):184-94.
2007: Richard A Campbell; Eric Sanchez; Jeffrey A Steinberg; Stavroula Baritaki; Melinda Gordon; Cathy Wang; Dror Shalitin; Haiming Chen; Shen Pang; Benjamin Bonavida; Jonathan Said; James R Berenson
Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.
British journal of haematology 2007;138(4):467-78.
2007: Stavroula Baritaki; Stavros Sifakis; Sara Huerta-Yepez; Ioannis K Neonakis; Giannoula Soufla; Benjamin Bonavida; Demetrios A Spandidos
Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.
International journal of oncology 2007;31(1):69-79.
2007: Haiming Chen; Melinda S Gordon; Richard A Campbell; Mingjie Li; Cathy S Wang; Hee Jin Lee; Eric Sanchez; Steven J Manyak; Dorina Gui; Dror Shalitin; Jonathan Said; Yunchao Chang; Thomas F Deuel; Stavroula Baritaki; Benjamin Bonavida; James R Berenson
Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth.
Blood 2007;110(1):287-95.
2007: Benjamin Bonavida
Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions.
Oncogene 2007;26(25):3629-36.
2007: Stavroula Baritaki; Sara Huerta-Yepez; Toshiyuki Sakai; Demetrios A Spandidos; Benjamin Bonavida
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
Molecular cancer therapeutics 2007;6(4):1387-99.
2007: Yoichi Mizutani; Hiroyuki Nakanishi; Yong Nan Li; Hiroki Matsubara; Kosuke Yamamoto; Nodoka Sato; Takumi Shiraishi; Terukazu Nakamura; Kazuya Mikami; Koji Okihara; Natsuki Takaha; Osamu Ukimura; Akihiro Kawauchi; Norio Nonomura; Benjamin Bonavida; Tsuneharu Miki
Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
International journal of oncology 2007;30(4):919-25.
2007: Alina Katsman; Kazuo Umezawa; Benjamin Bonavida
Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007;10(1-2):1-12.
2007: Ali R Jazirehi; Mario I Vega; Benjamin Bonavida
Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.
Cancer research 2007;67(3):1270-81.
2007: Stavroula Baritaki; Stavros Apostolakis; Peggy Kanellou; Marie-Thérèse Dimanche-Boitrel; Demetrios A Spandidos; Benjamin Bonavida
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications.
Advances in cancer research 2007;98():149-90.
2006: Benjamin Bonavida
What signals are generated by anti-CD20 antibody therapy?
Current hematologic malignancy reports 2006;1(4):205-13.
2006: Haiming Chen; Mingjie Li; Richard A Campbell; K Burkhardt; D Zhu; S G Li; Hee Jin Lee; Cathy Wang; Z Zeng; Melinda S Gordon; Benjamin Bonavida; James R Berenson
Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Oncogene 2006;25(49):6520-7.
2006: Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
Blood 2006;108(8):2745-54.
2006: Gohar Akopyan; Benjamin Bonavida
Understanding tobacco smoke carcinogen NNK and lung tumorigenesis.
International journal of oncology 2006;29(4):745-52.
2006: Sara Huerta-Yepez; Mario Vega; Hermes Garban; Benjamin Bonavida
Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Clinical immunology (Orlando, Fla.) 2006;120(3):297-309.
2006: Benjamin Bonavida; Soraya Khineche; Sara Huerta-Yepez; Hermes Garban
Therapeutic potential of nitric oxide in cancer.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2006;9(3):157-73.
2006: Richard A Campbell; Steven J Manyak; Honghao H Yang; Nelida N Sjak-Shie; Haiming Chen; Dorina Gui; Laura Popoviciu; Cathy Wang; Melinda Gordon; Shen Pang; Benjamin Bonavida; Jonathan Said; James R Berenson
LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma.
International journal of oncology 2006;28(6):1409-17.
2006: Howard S Yeh; Haiming Chen; Steven J Manyak; Regina A Swift; Richard A Campbell; Cathy Wang; Mingjie Li; Hee Jin Lee; Gabriel Waterman; Melinda S Gordon; Jonathan Ma; Benjamin Bonavida; James R Berenson
Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status.
British journal of haematology 2006;133(5):526-9.
2006: Lana Y Schumacher; Dan D Vo; Hermes Garban; Begoña Comin-Anduix; Sharla K Owens; Vivian B Dissette; John A Glaspy; william mcbride; Benjamin Bonavida; James S Economou; Antoni Ribas
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade).
Journal of immunology (Baltimore, Md. : 1950) 2006;176(8):4757-65.
2006: S Gordon; G Akopyan; Hermes Garban; Benjamin Bonavida
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.
Oncogene 2006;25(8):1125-42.
2005: Mario I Vega; Sara Huerta-Yepez; Ali R Jazirehi; Hermes Garban; Benjamin Bonavida
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
Oncogene 2005;24(55):8114-27.
2005: Benjamin Bonavida; Sara Huerta-Yepez; Lee Goodglick; Yoichi Mizutani; Tsuneharu Miki
Can we develop biomarkers that predict response of cancer patients to immunotherapy?
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2005;10 Suppl 1():S69-76.
2005: Fumiya Hongo; Hermes Garban; Sara Huerta-Yepez; Mario Vega; Ali R Jazirehi; Yoichi Mizutani; Tsuneharu Miki; Benjamin Bonavida
Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation.
Biochemical and biophysical research communications 2005;336(2):692-701.
2005: Mario I Vega; Ali R Jazirehi; Sara Huerta-Yepez; Benjamin Bonavida
Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(4):2174-83.
2005: David Seligson; Steve Horvath; Sara Huerta-Yepez; Stephanie Hanna; Hermes Garban; Alice Roberts; Tao Shi; Xueli Liu; David Chia; Lee Goodglick; Benjamin Bonavida
Expression of transcription factor Yin Yang 1 in prostate cancer.
International journal of oncology 2005;27(1):131-41.
2005: Ali R Jazirehi; Benjamin Bonavida
Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Oncogene 2005;24(13):2121-43.
2005: Benjamin Bonavida; Mario I Vega
Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2005;8(1-2):27-41.
2005: Yoichi Mizutani; Hiroyuki Nakanishi; Kosuke Yamamoto; Yong Nan Li; Hiroki Matsubara; Kazuya Mikami; Koji Okihara; Akihiro Kawauchi; Benjamin Bonavida; Tsuneharu Miki
Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):448-54.
2005: Ali R Jazirehi; Sara Huerta-Yepez; Genhong Cheng; Benjamin Bonavida
Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Cancer research 2005;65(1):264-76.
2004: Yoichi Mizutani; Hiroki Matsubara; Kosuke Yamamoto; Yong Nan Li; Kazuya Mikami; Koji Okihara; Akihiro Kawauchi; Benjamin Bonavida; Tsuneharu Miki
Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Cancer 2004;101(8):1794-802.
2004: Ali R Jazirehi; Mario I Vega; Devasis Chatterjee; Lee Goodglick; Benjamin Bonavida
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Cancer research 2004;64(19):7117-26.
2004: Sara Huerta-Yepez; Mario Vega; Ali R Jazirehi; Hermes Garban; Fumiya Hongo; Genhong Cheng; Benjamin Bonavida
Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Oncogene 2004;23(29):4993-5003.
2004: David Whiting; George R Hsieh; James J Yun; Anamika Banerji; William Yao; Michael C Fishbein; John A Belperio; Robert M Strieter; Benjamin Bonavida; Abbas Ardehali
Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(12):7417-24.
2004: Mario I Vega; Sara Huerta-Yepaz; Hermes Garban; Ali R Jazirehi; Christos Emmanouilides; Benjamin Bonavida
Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance.
Oncogene 2004;23(20):3530-40.
2004: Golaun Odabaei; Devasis Chatterjee; Ali R Jazirehi; Lee Goodglick; Kam Yeung; Benjamin Bonavida
Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis.
Advances in cancer research 2004;91():169-200.
2004: Ali R Jazirehi; Benjamin Bonavida
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
Molecular cancer therapeutics 2004;3(1):71-84.
2003: Ali R Jazirehi; Xiao-Hu Gan; Sven de Vos; Christos Emmanouilides; Benjamin Bonavida
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis.
Molecular cancer therapeutics 2003;2(11):1183-93.
2003: Corwin Hansch; Ali R Jazirehi; Suresh Babu Mekapati; Rajni Garg; Benjamin Bonavida
QSAR of apoptosis induction in various cancer cells.
Bioorganic & medicinal chemistry 2003;11(13):3015-9.
2003: Michael P Fischbein; James Yun; Hillel Laks; Yoshihito Irie; Laura Oslund-Pinderski; Michael C Fishbein; Benjamin Bonavida; Abbas Ardehali
Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts.
The Journal of thoracic and cardiovascular surgery 2003;126(1):216-23.
2003: Xiao-Hu Gan; Ling Zhang; David Heber; Benjamin Bonavida
Mechanism of activation of human peripheral blood NK cells at the single cell level by Echinacea water soluble extracts: recruitment of lymphocyte-target conjugates and killer cells and activation of programming for lysis.
International immunopharmacology 2003;3(6):811-24.
2003: C Cal; Hermes Garban; Ali R Jazirehi; C Yeh; Yoichi Mizutani; Benjamin Bonavida
Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
Current medicinal chemistry. Anti-cancer agents 2003;3(2):77-93.
2003: Sergio Huerta; Diane M Harris; Ali R Jazirehi; Benjamin Bonavida; David Elashoff; Edward H Livingston; David Heber
Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis.
International journal of oncology 2003;22(3):663-70.
2003: Corwin Hansch; Benjamin Bonavida; Ali R Jazirehi; J John Cohen; Cheri Milliron; Alka Kurup
Quantitative structure-activity relationships of phenolic compounds causing apoptosis.
Bioorganic & medicinal chemistry 2003;11(4):617-20.
2003: Patrick Frost; Randy Caliliw; Arie Belldegrun; Benjamin Bonavida
Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytes.
International journal of oncology 2003;22(2):431-7.
2003: Steve Alas; Benjamin Bonavida
Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):316-26.
2002: Christos Emmanouilides; Ali R Jazirehi; Benjamin Bonavida
Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):621-30.
2002: Chuen-Pei Ng; Amnon Zisman; Benjamin Bonavida
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
The Prostate 2002;53(4):286-99.
2002: Chuen-Pei Ng; Benjamin Bonavida
X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Molecular cancer therapeutics 2002;1(12):1051-8.
2002: Yoichi Mizutani; Osamu Yoshida; Osamu Ukimura; Akihiro Kawauchi; Benjamin Bonavida; Tsuneharu Miki
Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancer.
Cancer biotherapy & radiopharmaceuticals 2002;17(5):563-7.
2002: Xiaohu Gan; Ling Zhang; George F Solomon; Benjamin Bonavida
Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Brain, behavior, and immunity 2002;16(3):227-46.
2002: Michael P Fischbein; James Yun; Hillel Laks; Yoshihito Irie; Michael C Fishbein; Benjamin Bonavida; Abbas Ardehali
Role of CD8+ lymphocytes in chronic rejection of transplanted hearts.
The Journal of thoracic and cardiovascular surgery 2002;123(4):803-9.
2002: Shunsuke Mori; Kaoru Murakami-Mori; Shuji Nakamura; Benjamin Bonavida
Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent pathway.
International journal of oncology 2002;20(4):819-26.
2002: Steve Alas; Chuen-Pei Ng; Benjamin Bonavida
Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):836-45.
2002: Yoichi Mizutani; Hiromi Wada; Osamu Yoshida; Masakazu Fukushima; Benjamin Bonavida; Akihiro Kawauchi; Tsuneharu Miki
Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer.
Oncology reports 2002;9(2):289-92.
2002: Chuen-Pei Ng; Benjamin Bonavida
A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance.
Advances in cancer research 2002;85():145-74.
2002: Yoichi Mizutani; Hiroyuki Nakanishi; Osamu Yoshida; Masakazu Fukushima; Benjamin Bonavida; Tsuneharu Miki
Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.
European journal of cancer (Oxford, England : 1990) 2002;38(1):167-76.
2001: Ali R Jazirehi; Chuen-Pei Ng; Xiao-Hu Gan; Gary J Schiller; Benjamin Bonavida
Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3874-83.
2001: Steve Alas; Benjamin Bonavida
Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
Cancer research 2001;61(13):5137-44.
2001: M Keith Bechtel; Benjamin Bonavida
Inhibitory effects of 17beta-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase.
Gynecologic oncology 2001;82(1):127-38.
2001: Hermes Garban; Benjamin Bonavida
Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(1):75-81.
2001: Michael P Fischbein; James Yun; Hillel Laks; Yoshihito Irie; Michael C Fishbein; ML Espejo; Benjamin Bonavida; Abbas Ardehali
CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
Transplantation 2001;71(8):1146-53.
2001: Hermes Garban; Benjamin Bonavida
Nitric oxide disrupts H2O2-dependent activation of nuclear factor kappa B. Role in sensitization of human tumor cells to tumor necrosis factor-alpha -induced cytotoxicity.
The Journal of biological chemistry 2001;276(12):8918-23.
2001: Steve Alas; Christos Emmanouilides; Benjamin Bonavida
Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):709-23.
2001: P J Frost; Lisa H Butterfield; Vivian B Dissette; James S Economou; Benjamin Bonavida
Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(5):3564-73.
2001: Yoichi Mizutani; Masahiro Nakao; O Ogawa; Osamu Yoshida; Benjamin Bonavida; Tsuneharu Miki
Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
The Journal of urology 2001;165(1):263-70.
2000: Michael P Fischbein; Abbas Ardehali; J Yun; Stephen P Schoenberger; Hillel Laks; Y Irie; Paul W Dempsey; Genhong Cheng; Michael C Fishbein; Benjamin Bonavida
CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(12):7316-22.
2000: Steve Alas; Benjamin Bonavida; Christos Emmanouilides
Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab.
Anticancer research 2000;20(5A):2961-6.
2000: Anahid Jewett; Benjamin Bonavida
MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha.
Clinical immunology (Orlando, Fla.) 2000;96(1):19-28.
2000: P Frost; Benjamin Bonavida
Circumvention of tumor cell escape following specific immunotherapy.
Cancer biotherapy & radiopharmaceuticals 2000;15(2):141-52.
2000: M Itakura; Shunsuke Mori; No-Hee Park; Benjamin Bonavida
Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis.
International journal of oncology 2000;16(3):591-7.
2000: Kaoru Murakami-Mori; Shunsuke Mori; Benjamin Bonavida
Molecular pathogenesis of AIDS-associated Kaposi's sarcoma: growth and apoptosis.
Advances in cancer research 2000;78():159-97.
1999: Benjamin Bonavida; Chuen-Pei Ng; Ali R Jazirehi; Gary J Schiller; Yoichi Mizutani
Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics (review).
International journal of oncology 1999;15(4):793-802.
1999: P J Frost; Arie Belldegrun; Benjamin Bonavida
Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.
The Prostate 1999;41(1):20-30.
1999: Hermes Garban; Benjamin Bonavida
Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis.
Gynecologic oncology 1999;73(2):257-64.
1999: Shunsuke Mori; Kaoru Murakami-Mori; Shuji Nakamura; A Ashkenazi; Benjamin Bonavida
Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(9):5616-23.
1999: Xiao-Hu Gan; Benjamin Bonavida
Preferential induction of TNF-alpha and IL-1beta and inhibition of IL-10 secretion by human peripheral blood monocytes by synthetic aza-alkyl lysophospholipids.
Cellular immunology 1999;193(2):125-33.
1999: Shunsuke Mori; Kaoru Murakami-Mori; Benjamin Bonavida
Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells.
Biochemical and biophysical research communications 1999;257(2):609-14.
1999: Kaoru Murakami-Mori; Shunsuke Mori; Benjamin Bonavida; Shuji Nakamura
Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3672-9.
1999: Shunsuke Mori; Kaoru Murakami-Mori; Benjamin Bonavida
Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Anticancer research 1999;19(2A):1011-5.
1999: M Cavalcanti; Anahid Jewett; Benjamin Bonavida
Irreversible cancer cell-induced functional anergy and apoptosis in resting and activated NK cells.
International journal of oncology 1999;14(2):361-6.
1998: Shunsuke Mori; Kaoru Murakami-Mori; Benjamin Bonavida
Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines.
Anticancer research 1998;18(6A):4403-8.
1998: Shunsuke Mori; Anahid Jewett; M Cavalcanti; Kaoru Murakami-Mori; Shuji Nakamura; Benjamin Bonavida
Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.
International journal of oncology 1998;12(5):1165-70.
1997: Anahid Jewett; M Cavalcanti; Benjamin Bonavida
Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(10):4815-22.
1997: Patrick Frost; Chuen-Pei Ng; Arie Belldegrun; Benjamin Bonavida
Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
Cellular immunology 1997;180(1):70-83.
1997: Shunsuke Mori; Anahid Jewett; Kaoru Murakami-Mori; M Cavalcanti; Benjamin Bonavida
The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.
Cancer immunology, immunotherapy : CII 1997;44(5):282-90.
1997: A Demidem; T Lam; Steve Alas; Kandasamy Hariharan; Nabil Hanna; Benjamin Bonavida
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs.
Cancer biotherapy & radiopharmaceuticals 1997;12(3):177-86.
1997: Ruchan Uslu; N Borsellino; Patrick Frost; H Gárban; Chuen-Pei Ng; Yoichi Mizutani; Arie Belldegrun; Benjamin Bonavida
Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):963-72.
1997: Anahid Jewett; M Cavalcanti; Janis V Giorgi; Benjamin Bonavida
Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(11):5492-500.
1996: Ruchan Uslu; Anahid Jewett; Benjamin Bonavida
Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis.
Gynecologic oncology 1996;62(2):282-91.
1996: Shunsuke Mori; Kaoru Murakami-Mori; Anahid Jewett; S Nakamura; Benjamin Bonavida
Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.
Cancer research 1996;56(8):1874-9.
1996: Ruchan Uslu; Benjamin Bonavida
Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
Cancer 1996;77(4):725-32.
1996: Anahid Jewett; Benjamin Bonavida
Target-induced inactivation and cell death by apoptosis in a subset of human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(3):907-15.
1996: Anahid Jewett; X H Gan; L T Lebow; Benjamin Bonavida
Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation.
Journal of clinical immunology 1996;16(1):46-54.
1995: P F Hu; Lance E Hultin; P Hultin; Mary Ann Hausner; K Hirji; Anahid Jewett; Benjamin Bonavida; Roger Detels; Janis V Giorgi
Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(3):331-40.
1995: N Borsellino; A Belldegrun; Benjamin Bonavida
Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
Cancer research 1995;55(20):4633-9.
1995: A Jewett; Benjamin Bonavida
Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset.
Cellular immunology 1995;160(1):91-7.
1995: Anahid Jewett; Benjamin Bonavida
Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells.
Journal of clinical immunology 1995;15(1):35-44.
1995: D Hober; Anahid Jewett; Benjamin Bonavida
Lysis of uninfected HIV-1 gp120-coated peripheral blood-derived T lymphocytes by monocyte-mediated antibody-dependent cellular cytotoxicity.
FEMS immunology and medical microbiology 1995;10(2):83-91.
1995: Donna L Vredevoe; Debra Moser; X H Gan; Benjamin Bonavida
Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine.
Neuroimmunomodulation 1995;2(1):16-24.
1994: X H Gan; J P Robin; J M Huerta; P Braquet; Benjamin Bonavida
Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative.
Journal of clinical immunology 1994;14(5):280-8.
1994: Anahid Jewett; Benjamin Bonavida
Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
Cellular immunology 1994;154(1):273-86.
1994: Benjamin Bonavida; M Braquet; L T Lebow; Anahid Jewett
Qualitative and quantitative analysis of subpopulations of cytotoxic effector cells by flow cytometry.
Journal of lipid mediators and cell signalling 1994;9(1):19-25.
1994: Anahid Jewett; Benjamin Bonavida
Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion.
Journal of clinical immunology 1994;14(1):31-8.
1994: Benjamin Bonavida; J M Mencia-Huerta
Platelet-activating factor and the cytokine network in inflammatory processes.
Clinical reviews in allergy 1994;12(4):381-95.
1993: Anahid Jewett; Benjamin Bonavida
Pivotal role of endogenous TNF-alpha in the IL-2-driven activation and proliferation of the functionally immature NK free subset.
Cellular immunology 1993;151(2):257-69.
1993: Y Mizutani; Benjamin Bonavida
Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.
Cancer 1993;72(3):809-18.
1993: Benjamin Bonavida; L T Lebow; Anahid Jewett
Natural killer cell subsets: maturation, differentiation and regulation.
Natural immunity 1993;12(4-5):194-208.
1993: H Morimoto; S Yonehara; Benjamin Bonavida
Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
Cancer research 1993;53(11):2591-6.
1993: J T Safrit; A Belldegrun; Benjamin Bonavida
Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistance.
The Journal of urology 1993;149(5):1202-8.
1993: J T Safrit; Jonathan S Berek; Benjamin Bonavida
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
Gynecologic oncology 1993;48(2):214-20.
1993: L T Lebow; Anahid Jewett; Benjamin Bonavida
Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(1):320-9.
1993: H Morimoto; P Principe; J P Robin; C Broquet; J M Mencia-Huerta; P Braquet; Benjamin Bonavida
Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell lines.
Cancer chemotherapy and pharmacology 1993;32(4):293-300.
1993: Y Mizutani; Benjamin Bonavida
Pentoxifylline enhances sensitivity of a human ovarian cancer cell line (OVC-8) to TNF-alpha.
Biotherapy (Dordrecht, Netherlands) 1993;7(2):109-14.
1992: J T Safrit; Benjamin Bonavida
Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance.
Cancer research 1992;52(23):6630-7.
1992: H Morimoto; Benjamin Bonavida
Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(6):2089-94.
1992: X H Gan; Anahid Jewett; Benjamin Bonavida
Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha.
Natural immunity 1992;11(3):144-55.
1992: J T Safrit; Benjamin Bonavida
Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.
Cancer immunology, immunotherapy : CII 1992;34(5):321-8.
1991: H Morimoto; C Broquet; P Principe; J M Mencia-Huerta; P Braquet; Benjamin Bonavida
Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell lines.
Anticancer research 1991;11(6):2223-9.
1991: H Morimoto; J T Safrit; Benjamin Bonavida
Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(8):2609-16.
1991: Benjamin Bonavida
Immunomodulatory effect of tumor necrosis factor.
Biotherapy (Dordrecht, Netherlands) 1991;3(2):127-33.
1990: Anahid Jewett; Janis V Giorgi; Benjamin Bonavida
Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(12):4065-71.
1990: Benjamin Bonavida; T Tsuchitani; J Zighelboim; Jonathan S Berek
Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
Gynecologic oncology 1990;38(3):333-9.
1990: L T Lebow; Benjamin Bonavida
Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(16):6063-7.
1990: Y Nio; J Zighelboim; Jonathan S Berek; Benjamin Bonavida
Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers.
Anticancer research 1990;10(2A):441-6.
1990: Anahid Jewett; Benjamin Bonavida
Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC).
Clinical immunology and immunopathology 1990;54(2):192-9.
1990: Y Nio; J Zighelboim; Jonathan S Berek; Benjamin Bonavida
Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.
Natural immunity and cell growth regulation 1990;9(4):283-96.
1990: Benjamin Bonavida; J M Mencia-Huerta; P Braquet
Effects of platelet-activating factor on peripheral blood monocytes: induction and priming for TNF secretion.
Journal of lipid mediators 1990;2 Suppl():S65-76.
1989: Benjamin Bonavida; Anahid Jewett
Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-gamma.
Cellular immunology 1989;123(2):373-83.
1989: M P Chang; J Bramhall; S Graves; Benjamin Bonavida; B J Wisnieski
Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibition.
The Journal of biological chemistry 1989;264(26):15261-7.
1989: J D Katz; L T Lebow; Benjamin Bonavida
The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(4):1387-95.
1989: Y Nio; J Zighelboim; Jonathan S Berek; Benjamin Bonavida
Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells.
Cancer 1989;64(2):434-41.
1989: Y Hasegawa; Benjamin Bonavida
Calcium-independent pathway of tumor necrosis factor-mediated lysis of target cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(8):2670-6.
1989: Benjamin Bonavida; M Paubert-Braquet; D Hosford; P Braquet
The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
Progress in clinical and biological research 1989;308():485-9.
1989: Benjamin Bonavida; J M Mencia-Huerta; P Braquet
Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor.
International archives of allergy and applied immunology 1989;88(1-2):157-60.
1988: J D Katz; P Nishanian; Ronald T Mitsuyasu; Benjamin Bonavida
Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells.
Journal of clinical immunology 1988;8(6):453-8.
1988: J D Katz; K Ohnishi; L T Lebow; Benjamin Bonavida
The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype.
The Journal of experimental medicine 1988;168(5):1553-62.
1988: R L Baldwin; M P Chang; J Bramhall; S Graves; Benjamin Bonavida; B J Wisnieski
Capacity of tumor necrosis factor to bind and penetrate membranes is pH-dependent.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(7):2352-7.
1988: S C Wright; Anahid Jewett; Ronald T Mitsuyasu; Benjamin Bonavida
Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(1):99-104.
1988: Y Nio; J Zighelboim; Jonathan S Berek; Benjamin Bonavida
Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.
Cancer immunology, immunotherapy : CII 1988;27(3):246-54.
1988: J Zighelboim; Y Nio; Jonathan S Berek; Benjamin Bonavida
Immunologic control of ovarian cancer.
Natural immunity and cell growth regulation 1988;7(4):216-25.
1987: J D Katz; Ronald T Mitsuyasu; M S Gottlieb; L T Lebow; Benjamin Bonavida
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(1):55-60.
1987: K Ohnishi; Benjamin Bonavida
RCS tumor-host interactions: tumor growth dependence on L3T4+ T cells and its regulation by suppressor cells.
Progress in clinical and biological research 1987;244():359-68.